ALIA MULCAHY: Open Payments
NPI 1528010972 · WAIPAHU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 29 payments from 9 companies in 2025. Trend: 2023 $1,168 · 2024 $1,057 · 2025 $978
Food & beverage: $810Education: $168
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $325 |
| Sumitomo Pharma America, Inc. | 10 | $250 |
| Janssen Biotech, Inc. | 5 | $152 |
| PFIZER INC. | 3 | $91 |
| Teleflex LLC | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| UROGEN PHARMA, INC. | 1 | $28 |
| Ferring Pharmaceuticals Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: XTANDI, GEMTESA, ERLEADA, ORGOVYX, UROLIFT, Nubeqa, ADSTILADRIN, KEYTRUDA.
Industry payments across HI — which companies pay providers there.
